Statistics
Publications
34
Citations
8.8K
H-Index
23
Active since
2010
Weiwei Tan is an author at Pfizer (United States) specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
2010–2024
34
34
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
Alice T. Shaw, Sai‐Hong Ignatius Ou, Yung‐Jue Bang et al. · New England Journal of Medicine · 2014 · 2K citations
Medicine, Oncology, Pharmacology +17
CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib
Daniel B. Costa, Susumu Kobayashi, Shuchi S. Pandya et al. · Journal of Clinical Oncology · 2011 · 590 citations · Full text
Medicine, Oncology, Pharmacology +17
Sai‐Hong Ignatius Ou, Eunice L. Kwak, Christina T. Siwak-Tapp et al. · Journal of Thoracic Oncology · 2011 · 439 citations
Medicine, Oncology, Pharmacology +17
1–5 of 34